| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥3.4B | ¥6.1B | -43.2% |
| Operating Income | ¥-9.9B | ¥-4.3B | -128.6% |
| Ordinary Income | ¥-9.6B | ¥-4.5B | -116.2% |
| Net Income | ¥-9.3B | ¥-5.3B | -76.2% |
| ROE | -16.5% | -25.8% | - |
FY2025 Q3 cumulative results showed substantial deterioration across all metrics. Revenue declined to ¥3.4B (YoY -43.2%), reflecting severe contraction in the Investment segment. Operating income recorded a loss of ¥-9.9B (YoY -128.6%, prior period ¥-4.3B loss), driven by ¥10.4B in SG&A expenses against sharply reduced top-line revenue. Ordinary income posted ¥-9.6B loss (YoY -116.2%, prior ¥-4.5B loss), with limited support from ¥0.3B interest income. Net income attributable to owners reached ¥-9.3B (YoY -76.2%, prior ¥-5.3B loss), translating to basic EPS of ¥-1.85 (improved from ¥-2.25 YoY on per-share basis due to increased share count). Balance sheet expanded significantly to ¥70.5B total assets from ¥26.9B prior period, primarily through investment securities acquisition (¥8.4B vs ¥0.6B prior) and goodwill recognition (¥7.2B vs ¥3.4B prior) associated with Trust Corporation consolidation. Short-term borrowings surged to ¥5.5B from ¥0.3B, raising near-term refinancing concerns despite equity ratio maintaining 79.7% (prior 75.0%).
Revenue declined 43.2% YoY to ¥3.4B, concentrated entirely within the Investment segment which remains the sole operating business. The revenue contraction stems from reduced transaction volumes and diminished investment-related income flows during the nine-month period. Cost of sales decreased proportionally to ¥3.0B, yielding gross profit of ¥0.5B at 14.0% margin (prior period 18.6B gross profit at 30.6% margin), indicating margin compression alongside volume decline.
Operating loss expanded to ¥-9.9B from ¥-4.3B prior period, as SG&A expenses reached ¥10.4B (302.6% of revenue), substantially elevated from ¥6.2B prior period. This structural cost burden reflects organizational overhead that failed to adjust proportionally to revenue decline, alongside consolidation of newly acquired subsidiaries. The core issue represents a severe mismatch between fixed cost structure and declining revenue base.
Ordinary income of ¥-9.6B versus operating income of ¥-9.9B shows modest ¥0.3B net non-operating contribution, comprising ¥0.4B non-operating income (primarily ¥0.3B interest income and ¥0.1B FX gains) offset by ¥0.1B non-operating expenses (¥0.1B interest expense). The gap between ordinary and net income narrowed to ¥0.3B, reflecting ¥0.5B extraordinary income from investment securities sales and ¥0.1B extraordinary losses including ¥0.1B impairment and ¥0.8B asset disposal losses. Non-recurring factors contributed approximately ¥0.4B net positive impact, representing 11.6% of revenue but insufficient to offset operational losses. Segment notes disclose ¥442.6M goodwill recognition from Trust Corporation acquisition during the interim period, alongside ¥12.5M impairment charges on goodwill at Sanyo-Onoda Biomass Fuel Supply and Santec subsidiaries within the Investment segment.
This represents a revenue down/profit down pattern, with operational deterioration compounded by persistent cost structure rigidity.
The company operates exclusively through the Investment segment, which generated ¥3.4B revenue (YoY -43.2%) and recorded ¥-9.9B operating loss (YoY -128.6%, prior ¥-4.3B loss). Operating margin collapsed to -288.0%, down from -71.5% prior period, reflecting the widening gap between revenue contraction and fixed cost burden. As the core and sole business segment, Investment accounts for 100% of consolidated revenue and operating results, concentrating all business risk within capital markets exposure and portfolio company performance. The dramatic margin deterioration highlights fundamental business model stress under current operating conditions.
[Profitability] ROE stands at -16.5%, severely negative due to ¥-9.3B net loss against ¥56.2B equity base. Operating margin deteriorated to -288.4% from -71.5% prior period, indicating acute revenue-cost imbalance. Net profit margin reached -269.3%, reflecting loss at every income statement level. Asset turnover of 0.05x (annualized basis) remains extremely low, showing minimal revenue generation relative to expanded ¥70.5B asset base. [Cash Quality] Cash and deposits totaled ¥5.7B at period-end, representing 1.04x coverage of ¥5.5B short-term debt. Working capital of ¥26.2B provides 2.7x coverage of current liabilities, though composition includes ¥6.4B inventories and extended receivables. [Investment Efficiency] Days sales outstanding reached 130 days, indicating collection delays. Days inventory outstanding extended to 946 days, flagging slow-moving inventory concerns. Cash conversion cycle of 1,063 days reflects severe working capital inefficiency, with extended asset conversion periods straining liquidity. [Financial Health] Equity ratio maintained 79.7% (prior 75.0%), supported by ¥56.2B total equity despite accumulated losses reaching ¥-103.3B in retained earnings. Current ratio of 374.0% and quick ratio of 307.5% appear strong, but short-term debt ratio of 60.1% highlights refinancing dependency with ¥5.5B short-term borrowings due within 12 months. Debt-to-equity ratio of 0.16x remains modest, though interest coverage turned severely negative at -182.7x due to operating losses.
Cash and deposits increased ¥3.1B YoY to ¥5.7B, representing 121.9% growth despite deepening operating losses. This cash accumulation occurred alongside total asset expansion from ¥26.9B to ¥70.5B, suggesting external funding inflows rather than operating cash generation. Short-term borrowings surged ¥5.1B to ¥5.5B while long-term loans increased ¥3.0B to ¥3.6B, indicating ¥8.1B total debt financing raised during the period. Investment securities holdings expanded ¥7.8B to ¥8.4B, and goodwill/intangible assets increased ¥3.8B to ¥7.3B, pointing to substantial acquisition and investment activity absorbing capital. Working capital movements show trade receivables increasing ¥1.0B while inventories remained largely stable at ¥6.4B, suggesting revenue-related working capital buildup despite sales decline. Trade payables decreased ¥0.0B to ¥0.0B, indicating minimal supplier credit utilization. The balance sheet pattern reveals capital raised through debt financing was deployed toward investment securities purchases and M&A transactions (Trust Corporation consolidation per segment notes), while operating losses continued to consume cash internally. Current liquidity of ¥5.7B cash against ¥9.5B current liabilities provides 0.60x coverage, with short-term debt representing the dominant near-term obligation requiring refinancing or repayment within one year.
Ordinary income of ¥-9.6B versus operating income of ¥-9.9B reflects ¥0.3B net non-operating contribution, representing 8.7% of revenue in absolute terms. Non-operating income totaled ¥0.4B, composed primarily of ¥0.3B interest income from loan receivables and ¥0.1B foreign exchange gains, offset by ¥0.1B non-operating expenses including ¥0.1B interest expense on borrowings. These recurring non-operating items remain modest relative to core operations. Extraordinary items contributed ¥0.4B net positive impact, comprising ¥0.5B gain on investment securities sales partially offset by ¥0.1B impairment losses and ¥0.8B asset disposal losses. The securities sale gain represents non-recurring portfolio realization that does not reflect sustainable earnings power. Comprehensive income of ¥-9.3B closely matched net income of ¥-9.3B, with minimal ¥-0.0B foreign currency translation adjustment, indicating no material divergence between reported earnings and economic income. The alignment of comprehensive and net income confirms earnings quality is not distorted by unrealized OCI items. However, the substantial reliance on non-operating and extraordinary gains (¥0.4B combined) to partially offset ¥-9.9B operating losses highlights fundamental earnings weakness. Operating cash flow data remains undisclosed for the interim period, preventing direct assessment of cash-backed earnings quality through operating CF to net income comparison.
Full-year guidance projects revenue of ¥35.7B (YoY +408.3%), operating loss of ¥-6.8B, ordinary loss of ¥-7.0B, and net loss attributable to owners of ¥-9.9B, with zero dividend forecast. Q3 cumulative progress rates stand at revenue 9.6% (¥3.4B vs ¥35.7B target), operating loss 145.6% of full-year loss projection already incurred, and net loss 93.9% of full-year loss forecast already realized. These progress rates indicate severe underperformance on revenue generation (standard Q3 target 75%), while operating and net losses already exceed or approach full-year guidance levels. The company maintained guidance without revision during Q3 despite substantial shortfall, suggesting management anticipates Q4 revenue surge of approximately ¥32.3B to meet annual targets. However, no segment notes or forecast assumptions disclose specific drivers for this anticipated fourth-quarter recovery. The dramatic divergence between year-to-date results and full-year projections raises significant execution risk, particularly given the structural cost burden demonstrated through nine months. Investors should treat full-year revenue guidance with caution absent concrete visibility into deal pipeline or transaction closures scheduled for Q4.
Annual dividend forecast remains ¥0.00 per share, consistent with prior periods, reflecting the company's loss position and capital preservation priority. With basic EPS of ¥-1.85 for the nine-month period and full-year EPS forecast of ¥-1.94, dividend capacity remains absent under current earnings trajectory. No share buyback programs were disclosed or executed during the reporting period. The zero payout ratio reflects appropriate capital allocation given negative earnings and the need to conserve cash for debt service and operational requirements. Total return ratio to shareholders remains 0% for both dividends and buybacks. Given retained losses of ¥-103.3B accumulated through the period and ongoing operational cash consumption, dividend resumption requires sustained return to profitability and positive free cash flow generation. Management's dividend forecast of zero through fiscal year-end signals no near-term expectation of earnings recovery sufficient to support shareholder distributions.
Investment portfolio concentration risk remains paramount, with 100% of revenue and operating results stemming from the Investment segment, exposing the company entirely to capital markets volatility and portfolio company performance fluctuations. The ¥8.4B investment securities position (up ¥7.8B YoY) and ¥7.2B goodwill balance (up ¥3.8B YoY) represent substantial assets subject to market value decline and impairment risk. Segment notes confirm ¥12.5M impairment charges already taken at subsidiaries, signaling asset quality concerns may require further write-downs if portfolio companies underperform.
Short-term refinancing risk intensified with ¥5.5B short-term borrowings (up from ¥0.3B prior period) comprising 60.1% of total debt, creating concentrated maturity exposure within 12 months. Cash coverage of 1.04x against short-term debt provides minimal buffer, while operating losses of ¥-9.9B indicate inability to generate internal cash for repayment. Access to refinancing or debt rollover depends on lender confidence, which may deteriorate if FY2025 targets remain unmet.
Working capital management deterioration manifests through extended DSO of 130 days and DIO of 946 days, producing a 1,063-day cash conversion cycle that severely constrains liquidity. This prolonged asset conversion timeline indicates potential collection difficulties and inventory obsolescence issues that could necessitate write-downs or aggressive liquidation at unfavorable terms, further pressuring cash generation and balance sheet quality.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE -16.5% significantly underperforms the IT/Telecom industry median of 8.3% (2025-Q3, n=104), ranking at the bottom of the peer distribution and reflecting fundamental business model stress. Operating margin of -288.4% versus industry median of 8.2% (IQR 3.6%-18.0%) places the company in severe distress territory, with cost structure misalignment far exceeding normal industry ranges. Net profit margin of -269.3% compares unfavorably to industry median of 6.0% (IQR 2.2%-12.7%), confirming loss position is structural rather than cyclical.
Financial Health: Equity ratio of 79.7% exceeds industry median of 59.2% (IQR 42.5%-72.7%), indicating strong capital cushion despite operational losses. Current ratio of 374.0% substantially surpasses industry median of 2.15x (IQR 1.57x-3.62x), though this strength is offset by working capital inefficiency concerns noted in asset turnover metrics.
Efficiency: Asset turnover of 0.05x trails industry median of 0.67x (IQR 0.49-0.93), reflecting minimal revenue generation relative to expanded asset base and highlighting severe capital deployment inefficiency. The company's working capital cycle metrics (1,063 days CCC) far exceed industry norms, where median operating working capital turnover stands at 45 days (IQR 25-68 days), signaling acute operational management deficiencies.
Growth: Revenue decline of -43.2% YoY sharply contrasts with industry median revenue growth of +10.4% (IQR -1.1% to +19.5%), positioning the company as a significant underperformer in a generally expanding sector. EPS decline, while improved on a per-share basis due to share count changes, remains deeply negative versus industry median EPS growth of +22%.
(Industry: IT/Telecom sector, Comparison: 2025-Q3 period with sample sizes ranging from 88-104 companies depending on metric availability, Source: Proprietary analysis)
Structural profitability crisis is evident, with operating losses expanding to ¥-9.9B on ¥3.4B revenue, driven by ¥10.4B SG&A expense burden that represents 302.6% of sales. This cost structure cannot sustain current business volumes and requires immediate intervention through organizational restructuring, overhead reduction, or business model transformation. The -288.4% operating margin places the company in financial distress territory, demanding urgent action to align costs with realistic revenue expectations rather than reliance on optimistic Q4 recovery scenarios embedded in unrevised full-year guidance.
Balance sheet transformation through M&A and portfolio expansion created ¥70.5B asset base (up from ¥26.9B), funded substantially by ¥8.1B debt increase including ¥5.1B short-term borrowings. This rapid leverage escalation occurred simultaneously with operational deterioration, raising concerns about capital allocation discipline and near-term debt servicing capacity. The ¥7.2B goodwill balance and ¥8.4B investment securities holdings represent substantial evaluation-sensitive assets vulnerable to further impairment if portfolio companies underperform, potentially triggering additional losses and eroding the currently strong 79.7% equity ratio.
Working capital deterioration signals operational control weakness, with 1,063-day cash conversion cycle indicating severely extended asset realization periods. Combined with DSO of 130 days and DIO of 946 days, these metrics suggest collection challenges and inventory quality issues that could force asset liquidation at distressed values if liquidity pressures intensify. Despite ¥5.7B cash position, coverage of ¥5.5B short-term debt at only 1.04x provides minimal refinancing cushion, particularly concerning given negative operating cash generation prevents natural debt amortization through business operations.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.